Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2025-07-22 00:00:00 ET · period of report 2025-07-18 · accession 0001415889-25-020123 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-22 | 2025-07-18 | AMPH | Gaugh David Russell | Dir | A - Grant | $0.00 | +6,304 | 6,304 | New | $0 |
| D | 2025-07-22 | 2025-07-18 | AMPH | Gaugh David Russell | Dir | A - Grant | $0.00 | +14.0K | 14.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-18 | A | A | 6,304 | $0.00 | 6,304 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, all of which vest on July 18, 2026. |
| 2 | Derivative | Stock Option (right to buy) | 2025-07-18 | A | A | 13,987 | $0.00 | 13,987 | D | $20.62 · — to 2035-07-18 | 13,987 Common Stock | (F2) All of the shares subject to the option vest on July 18, 2026. |